The 3 Most Popular Data Engineering Tools are MongoDB, Tableau, and Kubernetes, New Study by Dattell Finds – Yahoo Finance

Over 3.5 Billion Data Points Were Collected and Studied to Uncover the Most Popular Data Engineering Tools and Best Jobs in the Field
SAN DIEGO, June 27, 2022 /PRNewswire/ — The 5 most popular data engineering tools are MongoDB, Tableau, Kubernetes, PostgreSQL, and Ansible, according to a new industry study by Dattell.
The study also looked at job data to determine which specialties are in highest demand by employers and which ones have the highest salaries.
The study was conducted by collecting 3.5 billion data points to assess the popularity of 59 data engineering tools that fell into the following categories:  Data Processing, Data Orchestration, Data Storage, Data Visualization, and Languages/Libraries. A full research methods document is linked in the report.
The major findings uncovered by the study include:
5 most popular technologies. The most popular technologies are MongoDB, Tableau, Kubernetes, PostgreSQL, and Ansible.
340,000 Job Openings. There are over 340,000 open data engineering jobs.
Kubernetes highest paying specialty. There is a 3-fold range of salaries for data engineering jobs, with Kubernetes paying the highest, with salaries reaching $180,000, and Tableau paying the lowest.
Companies opting for free data processing tools. Free data processing tools are preferred 62% of the time, over paid alternatives.
Industry split on whether to pay for data storage. Data engineers are split on whether to pay for data storage tools, with the top four storage tools being an equal mix of paid and free tools.
Python most important language. Python is the most popular programming language, followed by Java and SQL.
Clear winners in the data orchestration space. Kubernetes and Ansible control 65% of the data orchestration space.
Companies preferring to pay for data visualization tools. The top 10 data visualization tools are all paid tools.
View the complete results of this data engineering study:
About Dattell.  Dattell is a leading provider of data infrastructure consulting services for mid-size and Fortune 100 companies, including resident solution architects, managed services for on-prem and cloud-based data systems, and virtual CIO services.  For more information please visit
If you have any questions regarding this Press Release, please email us at
Media Contact:
Maria Hatfield
View original content to download multimedia:
Within the tech sector, shares of Shopify (NYSE: SHOP), Palantir Technologies (NYSE: PLTR), and CrowdStrike (NASDAQ: CRWD) are suffering worse than most, falling 3.3%, 3.9%, and 8%, respectively, through 12:05 p.m. ET. You can blame investment bank Jefferies for that — and Piper Sandler, too. Jefferies started off the new year with a series of downgrades, reversing its buy ratings and lowering Shopify, Palantir, and CrowdStrike to neutral, as ratings-watcher The Fly reports today.
MACCO CEO Drew McManigle joins Yahoo Finance Live to weigh in on Bed Bath & Beyond and why the retailer is likely doomed sooner than later. 
The billionaire investor tells TheStreet that a new scandal will soon rock the cryptocurrency industry.
Adding Novocure's medical device to standard drugs improved survival for late-stage lung cancer patients, leading NVCR stock to soar Thursday.
Early-stage companies like Rivian Automotive (NASDAQ: RIVN), Lucid Group (NASDAQ: LCID), and Canoo (NASDAQ: GOEV) took some of the biggest hits, dropping by between about 5% and 8% at their lows of the morning. As of 1 p.m. ET, those three stocks were lower by 6.1%, 3.4%, and 6.9%, respectively. As fourth-quarter EV delivery data has begun trickling out this week, investors are growing more and more concerned about the pace of expected growth in the industry.
Shares of Novocure (NASDAQ: NVCR) are skyrocketing 49.8% higher as of 10:12 a.m. ET on Thursday. The huge jump came after the company announced the results from a late-stage clinical study evaluating its Tumor Treating Fields (TTFields) therapy in treating stage 4 non-small cell lung cancer (NSCLC). Novocure reported that TTFields in combination with standard therapies met the primary endpoint of the phase 3 study by achieving statistically significant improvement in overall survival compared to standard therapies alone.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Amy Hubble, principal investment advisor at Radix Financial in Oklahoma City, said for those with savings still parked in a low yielding bank account, now is the time to act.
Geron (GERN) posts positive top-line data from the phase III IMerge study investigating its lead candidate, imetelstat for treating lower risk myelodysplastic syndromes. Shares up.
The memory giant rose on reports that China may be throwing in the towel on subsidizing competitors.
Shares of Silvergate Capital plummeted more than 40% as the fallout from the FTX collapse continues throughout the crypto space.
'Because of the 2.5% rate, none of us are interested in selling the house and getting our rates jacked up to 7%.'
These are some of the stocks moving in after hours on Jan. 5, 2023.
The current rate is good, but if you hold off until just before the next change, it could be even better.
As 2023 starts gearing up for the long haul, Wall Street is still taking a bearish view of the markets. We’re still dealing with the same headwinds, a combination of stubbornly high inflation, rapidly rising interest rates, gloomy economic indicators, the continuing war in Ukraine, uncertainty over China’s lockdown policies, a supply chain that is only slowly unsnarling itself… the list can go on. But despite the grim outlook right now, there are still some signals that give reasons for longer-t
Analysts say minutes of the Federal Reserve's December meeting delivered an important message to investors: big stock market rallies are unwelcome.
Cybersecurity stocks are getting hit particularly hard today, with shares of Fortinet (NASDAQ: FTNT) falling 1.1% as of 11:10 a.m. EST, Palo Alto Networks (NASDAQ: PANW) down 3.3%, and Zscaler (NASDAQ: ZS) leading the whole pack lower with a 4.9% loss. Tic-tac-toe, three in a row, Piper Sandler started off the New Year with a series of lowered price targets in the cyber sector this morning, reports ratings watcher TheFly. The banker cut Fortinet's price target 5% to $57 a share and made Palo 4% less "Alto" at $220.
ExxonMobil (NYSE: XOM) is starting to feel the pinch of lower oil prices. The oil giant's profits could continue declining in 2023 if oil and gas prices don't perk back up. The company's profit slump might have investors wondering if it's time to sell.
On Wednesday, Microsoft shares gave up more than $10, or 4.37%. Amazon had a better day than Microsoft, surrendering just 0.79% for the session after having confirmed that it would be taking on some more debt, under somewhat shaky circumstances. Amazon confirmed in an SEC filing that it had reached an agreement with certain lenders to provide it with an unsecured $8B loan to be used for general corporate purposes.
The declines put both indexes firmly in bear market territory. One person who knows a thing or two about investing in bear markets is Berkshire Hathaway CEO Warren Buffett. Since taking control of Berkshire Hathaway in 1965, Buffett has helped the holding company generate returns of roughly 2,419,900% for investors — crushing the S&P 500's returns in the process.
After a tough 2022, this could be the year that fixed income is a better bet than stocks. Here’s what some of the experts recommend buying now.


Leave a Comment